RLYB
Rallybio Corp
17.10$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.7% | -2.8% | -2.9% | -5.9% | -6.3% | -6.7% | -7.1% | +34.6% | -91.4% | +0.0% | -33.3% | – | |
| – | -3.2% | -18.1% | -8.3% | +5.8% | -3.2% | -4.3% | -14.1% | -35.1% | -26.1% | -20.8% | -30.8% | – | |
| – | – | -78.5% | +191.5% | -234.3% | – | – | – | – | – | -153.8% | – | – | |
| – | +290.9% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +450.8% | -39.3% | -74.7% | +755.4% | -107.1% | – | -72.6% | +863.0% | -86.6% | +356.1% | -69.3% | – | |
| – | – | – | – | – | -59.1% | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | -100.2% | – | -100.0% | – | -100.0% | – | -50.0% | +4,600.0% | – | |
| – | – | -197.3% | – | – | -232.0% | – | -708.9% | – | -103.3% | – | +415.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.